How much has Nudge raised?
Nudge has $100M disclosed in disclosed or reported funding. The latest public valuation/status is Not publicly disclosed.
- Total raised
- $100M disclosed
- Disclosed rounds
- 1 major disclosed entries
- Latest round
- Series A ($100M)
- Latest valuation
- Not publicly disclosed
- First raised
- Jul 2025 Series A
- Notable backer
- Thrive Capital and Greenoaks
Nudge's funding rounds
Nudge's public funding trajectory runs from Jul 2025 to Jul 2025.
- Jul 2025Series A — valuation not disclosed$100M led/backed by Thrive Capital and Greenoaks.
How much has Nudge raised in total?
Nudge has $100M disclosed in disclosed or reported funding. The profile lists only public amounts and clearly marks undisclosed valuations or rounds.
The major funding entries are Jul 2025 Series A: $100M, valuation not disclosed, led/backed by Thrive Capital and Greenoaks.
Who are Nudge's investors?
Notable investors or backers include Thrive Capital and Greenoaks. These investors are relevant because they shape board expectations around growth, governance, hiring, and follow-on capital discipline.
Why did the valuation move or stay undisclosed?
No current valuation is public, so there is no reliable valuation movement to analyze. The better signal is the company's stage, funding recency, customer or care footprint, and hiring momentum.
Is Nudge profitable, and will it IPO?
Nudge has not publicly disclosed audited profitability or IPO timing. Treat IPO readiness as speculative until management files, announces a transaction, or publishes financials.
What does Nudge's funding mean if you sell into them?
The funding signal suggests budget capacity, but not automatic spend. Sellers should map to the active initiative funded by the round: market expansion, clinical operations, AI/data tooling, compliance, workforce, integrations, or payer/provider partnerships.
As of June 2026.Sources:Nudge homepageNudge Series ANudge LinkedInQuintin Frerichs personal site
Nudge — frequently asked questions
